Company news
IN8bio, Inc. news in 2025
IN8bio, Inc.'s news releases, calls and decks from 2025, newest first.
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
December 19, 2025
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 6, 2025
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
October 29, 2025
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
October 27, 2025
IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 7, 2025
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
June 9, 2025
IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
June 2, 2025
IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025
May 14, 2025
IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products
May 12, 2025
IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 7, 2025
IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences
April 29, 2025
IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
April 28, 2025
IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
March 31, 2025
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
March 18, 2025
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
March 13, 2025
IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
March 3, 2025
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
February 26, 2025
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
February 24, 2025
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
February 10, 2025